Loading clinical trials...
Loading clinical trials...
Randomized Clinical Study Comparing the Effectiveness of the Stanford Letter to the Traditional Advance Directive in Bone Marrow Transplant Recipients
Conditions
Interventions
Stanford Letter
Interview
+2 more
Locations
1
United States
Stanford University, School of Medicine
Palo Alto, California, United States
Start Date
March 3, 2017
Primary Completion Date
September 14, 2018
Completion Date
July 27, 2021
Last Updated
June 14, 2022
NCT04276870
NCT06910969
NCT04645199
NCT06398457
NCT01163578
NCT06936566
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions